ARCUTIS BIOTHERAPEUTICS INC shareholders Q3 2023

ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 136 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 4.21 and the average weighting 0.1%.

ARCUTIS BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
NEW YORK STATE COMMON RETIREMENT FUND 15,041$800.00%
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 14,697$78,0410.00%
DEUTSCHE BANK AG\ 30,362$161,2220.00%
CREDIT SUISSE AG/ 57,477$305,2030.00%
MONTAG A & ASSOCIATES INC 500$2,6550.00%
UBS ASSET MANAGEMENT AMERICAS LLC 81,080$430,5350.00%
GOLDMAN SACHS GROUP INC 333,010$1,768,2840.00%
MORGAN STANLEY 222,040$1,179,0310.00%
ASSETMARK, INC 1,860$9,8770.00%
COMERICA BANK 90$4780.00%
Invesco Ltd. 25,073$133,1370.00%
AMALGAMATED BANK 7,439$400.00%
ProShare Advisors LLC 10,708$56,8590.00%
Zurcher Kantonalbank (Zurich Cantonalbank) 6,060$32,1790.00%
Bank of New York Mellon Corp 237,779$1,262,6060.00%
LPL Financial LLC 83,513$443,4540.00%
Citadel Advisors 11,400$60,5340.00%
Citadel Advisors 24,600$130,6260.00%
Citadel Advisors 250,535$1,330,3410.00%
CAPSTONE INVESTMENT ADVISORS, LLC 20,198$107,2510.00%
External links

This page lists ARCUTIS BIOTHERAPEUTICS INC's shareholders in Q3 2023. To view ARCUTIS BIOTHERAPEUTICS INC's shareholder history, click here.